BioNTech cuts 1,860 jobs as vaccine sales collapse

The fact

This drastic reduction follows the collapse in COVID-19 vaccine sales, whose revenues have plummeted significantly since their 2021 peak.

Three production sites in Germany are directly affected by this major restructuring plan.